Identify which type of immunity each example represents.

The correct answers are:

• Immunoglobulin administration: Passive – Artificial Immunity
• Antibodies produced by body after exposure to live pathogen: Active – Natural Immunity
• Vaccine administration: Active – Artificial Immunity
• Antibodies passed from mother to fetus: Passive – Natural Immunity
• Antibodies produced by body after exposure to attenuated virus: Active – Artificial Immunity

A. Immunoglobulin administration involves injecting pre-formed antibodies from an external source, such as human or animal serum, to provide immediate but temporary protection. This does not stimulate the recipient’s immune system to produce antibodies or memory cells, aligning with passive – artificial immunity.

B. Exposure to a live pathogen triggers the body’s immune system to produce antibodies and memory cells, conferring long-term protection. This natural process of immune activation matches active – natural immunity, as the body actively responds to the pathogen without artificial intervention.

C. Vaccine administration introduces attenuated or inactivated pathogens, prompting the immune system to produce antibodies and memory cells without causing disease. This artificial induction of immunity aligns with active – artificial immunity, as it mimics natural infection but is deliberately administered.

D. Antibodies passed from mother to fetus, primarily immunoglobulin G (IgG) through the placenta, provide temporary protection to the newborn without active immune response. This natural transfer of antibodies corresponds to passive – natural immunity, as it occurs without medical intervention.

E. Exposure to an attenuated virus via vaccination stimulates the immune system to produce antibodies and memory cells, offering long-term protection. This controlled, artificial exposure aligns with active – artificial immunity, as it involves deliberate administration of a weakened pathogen to induce an immune response.

A. A single IV line allows simultaneous administration of multiple drugs, but compatibility must be confirmed. Morphine and ketorolac are generally compatible for IV administration, but a dedicated line is preferred to avoid potential precipitation or chemical interactions that could reduce efficacy or cause harm. A dedicated line ensures each drug is delivered without interference, aligning with safe administration practices for this patient’s pain management.

B. A Y-site IV configuration allows drugs to mix at the infusion site, which could lead to incompatibility. Morphine, an opioid, and ketorolac, an NSAID, have different chemical properties, and while no major incompatibility is documented, using a Y-site risks minor interactions or reduced efficacy, making it less ideal than a dedicated line for this patient.

C. Flushing the IV line ensures patency but does not address drug compatibility. Morphine and ketorolac administration through the same line without a dedicated setup could lead to precipitation or reduced effectiveness, especially if not flushed properly between doses. This option is insufficient for ensuring safe delivery in this context.

D. Ketorolac, an NSAID, can cause gastrointestinal or renal side effects but does not directly interfere with morphine’s action. However, simultaneous administration through the same IV line could risk chemical incompatibility, such as precipitation, which could obstruct the line or reduce drug efficacy, making this a critical consideration for the patient’s IV setup.

E. Morphine, an opioid, provides analgesia but does not inherently interfere with ketorolac’s action. The concern lies in their co-administration through the same IV line, where potential chemical interactions could occur, supporting the need for a dedicated line to ensure both drugs are delivered effectively for the patient’s pain control.

F. Heparin, an anticoagulant, is not mentioned in the provider’s orders. Interference with heparin is irrelevant here, as the focus is on morphine and ketorolac compatibility. This option is incorrect, as it does not address the patient’s medication regimen or IV administration concerns.

G. Saline is used for flushing IV lines to maintain patency, not as a primary drug. It does not interfere with morphine or ketorolac but is irrelevant to the question of drug interference, making this option incorrect for the patient’s pain management context.

H. Precipitation occurs when incompatible drugs mix, forming insoluble particles that can clog the IV line or reduce drug efficacy. Morphine and ketorolac have a low risk of precipitation, but a dedicated line minimizes this risk, ensuring safe and effective delivery, making this a correct consideration for the patient’s IV setup.

I. Flushing between drug administrations prevents mixing but does not eliminate the need for a dedicated line. While flushing reduces interaction risks, it is less reliable than a dedicated line for ensuring morphine and ketorolac are administered without interference, making this option less optimal for the patient’s needs.